TAPUR Study Launches to Evaluate Off-Label Uses of Targeted Cancer Therapies
From - Diagnostic Testing & Emerging Technologies The Targeted Agent and Profiling Utilization Registry (TAPUR) study began recruiting its first patients last month. The trial, the first clinical trial undertaken by … . . . read more
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article